Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Mar 27 04:00PM ET
92.97
Dollar change
0.00
Percentage change
0.00
%
Index- P/E22.68 EPS (ttm)4.10 Insider Own0.01% Shs Outstand237.73M Perf Week3.30%
Market Cap22.10B Forward P/E- EPS next Y-1.76 Insider Trans0.00% Shs Float237.71M Perf Month0.19%
Income998.75M PEG- EPS next Q-0.95 Inst Own17.84% Short Float1.30% Perf Quarter-11.23%
Sales4.12B P/S5.37 EPS this Y-142.79% Inst Trans12.40% Short Ratio4.46 Perf Half Y-8.73%
Book/sh94.08 P/B0.99 EPS next Y0.56% ROA3.97% Short Interest3.08M Perf Year-24.78%
Cash/sh54.20 P/C1.72 EPS next 5Y- ROE4.56% 52W Range85.21 - 131.52 Perf YTD-11.91%
Dividend Est.- P/FCF4.02 EPS past 5Y- ROI4.42% 52W High-29.31% Beta0.22
Dividend TTM- Quick Ratio9.26 Sales past 5Y843.27% Gross Margin84.24% 52W Low9.10% ATR (14)2.85
Dividend Ex-DateJun 02, 2022 Current Ratio9.43 EPS Y/Y TTM-89.95% Oper. Margin22.76% RSI (14)50.18 Volatility2.97% 2.93%
Employees3082 Debt/Eq0.01 Sales Y/Y TTM-77.63% Profit Margin24.26% Recom2.17 Target Price119.63
Option/ShortYes / Yes LT Debt/Eq0.01 EPS Q/Q-78.45% Payout0.00% Rel Volume0.00 Prev Close92.97
Sales Surprise-19.12% EPS Surprise-19.93% Sales Q/Q-63.55% EarningsMar 20 BMO Avg Volume691.25K Price92.97
SMA200.87% SMA50-0.71% SMA200-9.74% Trades Volume0 Change0.00%
Date Action Analyst Rating Change Price Target Change
Feb-23-24Initiated BMO Capital Markets Outperform $127
Jan-05-24Initiated Oppenheimer Perform
Dec-01-23Downgrade JP Morgan Neutral → Underweight $106 → $99
Oct-16-23Downgrade HSBC Securities Buy → Hold $124 → $111
Jul-14-23Initiated HSBC Securities Buy $124
May-17-23Upgrade Redburn Neutral → Buy $165 → $170
Dec-15-22Upgrade BofA Securities Neutral → Buy $239
Aug-17-22Initiated Cowen Market Perform $177
Jul-13-22Upgrade SVB Leerink Mkt Perform → Outperform
Jul-06-22Resumed Canaccord Genuity Buy $192
Mar-26-24 09:53AM
01:00AM
Mar-25-24 06:47AM
06:19AM
Mar-21-24 11:38AM
01:43AM Loading…
01:43AM
Mar-20-24 04:45PM
03:56PM
03:38PM
02:45PM
11:05AM
10:34AM
09:20AM
09:09AM
07:49AM
06:22AM Loading…
06:22AM
06:17AM
06:15AM
06:15AM
06:00AM
Mar-17-24 09:19AM
08:50AM
Mar-15-24 05:53AM
Mar-14-24 01:51PM
Mar-13-24 11:07AM
Mar-11-24 03:29PM
07:45AM
Mar-09-24 01:09PM
Mar-08-24 01:25AM
Mar-07-24 06:45AM
04:45PM Loading…
Mar-06-24 04:45PM
06:45AM
Mar-05-24 04:16AM
Mar-04-24 06:42PM
05:33PM
10:06AM
Mar-02-24 10:42AM
Feb-27-24 05:45AM
Feb-26-24 12:29PM
10:27AM
Feb-23-24 01:00PM
Feb-14-24 06:35PM
Feb-08-24 06:07AM
05:45AM
Feb-04-24 06:56AM
Feb-02-24 02:39PM
Feb-01-24 06:30AM
Jan-31-24 06:45AM
Jan-25-24 09:55AM
Jan-24-24 11:30AM
Jan-22-24 06:45AM
06:45AM
Jan-17-24 11:30AM
Jan-09-24 04:16PM
07:37AM
07:12AM
07:09AM
06:52AM
06:45AM
06:45AM
Dec-28-23 12:00AM
Dec-24-23 05:34PM
Dec-21-23 08:00AM
Dec-19-23 12:31PM
09:12AM
08:35AM
Dec-18-23 01:15PM
10:06AM
05:50AM
Dec-15-23 12:02PM
Dec-12-23 03:04PM
06:45AM
Dec-08-23 10:13AM
Dec-05-23 07:59AM
Dec-01-23 05:32AM
Nov-28-23 01:34PM
01:34PM
Nov-21-23 09:04AM
05:37AM
Nov-14-23 04:17PM
Nov-09-23 10:01PM
Nov-07-23 08:39AM
05:13AM
Nov-06-23 04:30PM
04:21PM
04:03PM
01:40PM
12:48PM
12:13PM
12:13PM
11:56AM
11:00AM
10:57AM
09:34AM
09:04AM
08:48AM
08:41AM
08:06AM
07:48AM
06:48AM
BioNTech SE operates as immunotherapy company, which engages therapies for cancer and other serious diseases. Its product pipeline include BNT162b2, BNT161, BNT164, FixVac, iNeST, RiboMabs, CAR-T Cells, TCRs and Next-Gen CP Immunomodulators. The company was founded by Christopher Huber, Oezlem Tuereci, and Ugur Sahin on June 2, 2008 and is headquartered in Mainz, Germany.